NASDAQ : QLGN

Qualigen Therapeutics, Inc. — Earnings Estimates

$3.21 USD

$0.17 (5.59%)

Volume
368.77K
Average Volume
2.65M
Market Capitalization
$5.43M
P/E Ratio
-0.51
Dividend Yield
0.00%
Price Target
Year High
$8.81
Year Low
$1.61
Day High
Day Low
Payout Ratio
-$0.07
Current Ratio
$3.68

Annual earnings financials

QLGN financial data with annual/quarterly toggle

QLGN GAAP EPS - Annual & Quarterly

QLGN Sales Revenue - Annual & Quarterly

QLGN Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

QLGN Estimated and Actual Revenue by Quarter
QLGN Estimated and Actual EPS by Quarter
QLGN Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-09-30 0 - - - - - -
2028-06-30 1 -300K -300K -300K -300K -300K -300K
2028-03-30 1 -960K -960K -960K -960K -960K -960K
2027-12-30 1 -840K -840K -840K -840K -840K -840K
2027-09-30 1 -900K -900K -900K -900K -900K -900K
2027-06-30 1 -972K -972K -972K -972K -972K -972K
QLGN Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-09-30 0 -527.44M -527.44M -527.44M - - -
2028-06-30 1 -933.16M -933.16M -933.16M 866.13K 866.13K 866.13K
2028-03-30 1 -527.44M -527.44M -527.44M 2.77M 2.77M 2.77M
2027-12-30 1 -862.16M -862.16M -862.16M 2.43M 2.43M 2.43M
2027-09-30 1 -1.42B -1.42B -1.42B 2.6M 2.6M 2.6M
2027-06-30 1 -1.42B -1.42B -1.42B 2.81M 2.81M 2.81M
QLGN Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-09-30 0 - - - 1 -26 -26 -26
2028-06-30 1 500K 500K 500K 1 -46 -46 -46
2028-03-30 1 1.6M 1.6M 1.6M 1 -26 -26 -26
2027-12-30 1 1.4M 1.4M 1.4M 1 -42.5 -42.5 -42.5
2027-09-30 1 1.5M 1.5M 1.5M 1 -70 -70 -70
2027-06-30 1 1.62M 1.62M 1.62M 1 -70 -70 -70